Bottom line: **g180b kills the frozen g180 universality story.** It does not kill g182, but it makes g182’s only credible win condition much narrower: **reference-free, residualized geometry must beat arm/protocol and combined telemetry.**

The WIKI is stale on g180b status; the completed verdict is in [EXPERIMENTS.md](<C:/Users/devan/OneDrive/Desktop/Projects/AI Moonshots/moonshot-llm-genome/experiments/EXPERIMENTS.md:41>) and the JSON: 27/27 rows, MSE reduction `-39.4%`, CI entirely negative, `p_gt_0=0.0142` [results/genome_180b_cross_tokenizer.json](<C:/Users/devan/OneDrive/Desktop/Projects/AI Moonshots/moonshot-llm-genome/results/genome_180b_cross_tokenizer.json:6902>). Per-tokenizer: BERT/T5 fail hard, GPT-2 wins [results](<C:/Users/devan/OneDrive/Desktop/Projects/AI Moonshots/moonshot-llm-genome/results/genome_180b_cross_tokenizer.json:7033>). Shuffled geometry `p=0.999` means the learned geometry ordering is anti-informative [results](<C:/Users/devan/OneDrive/Desktop/Projects/AI Moonshots/moonshot-llm-genome/results/genome_180b_cross_tokenizer.json:7117>).

**1. Three Next Directions**

1. **g182-strict: residualized pure/reference-free geometry.**  
   Make A12 the real gate: residualize against `arm_mean` / protocol, beat `combined_telemetry`, remove Qwen-reference features, and do not let “KD arm hurts” masquerade as geometry. This is already the attack register’s central demand [CLAIM_EVIDENCE_MAP.md](<C:/Users/devan/OneDrive/Desktop/Projects/AI Moonshots/moonshot-llm-genome/research/CLAIM_EVIDENCE_MAP.md:123>). If geometry cannot add signal beyond protocol and telemetry, the diagnostic line is dead.

2. **Phase-2 SSM/hybrid extension if g182 has any clean signal.**  
   g182 with Qwen3 + GPT-2 is still only cross-Transformer; the prereg itself says non-attention family is needed for 9.0 [genome_182 prereg](<C:/Users/devan/OneDrive/Desktop/Projects/AI Moonshots/moonshot-llm-genome/research/prereg/genome_182_triage_arena_2026-04-29.md:28>). g180b’s GPT-2-only win makes this more urgent: Qwen→GPT-2 may just be nearest-family tokenizer transfer.

3. **g183 corpus-derived interface prior.**  
   g181a/g181b/g180b all point to the same mechanism: tokenizer/embed/lm_head interface prior, not internal “genome transfer” [CLAIM_EVIDENCE_MAP.md](<C:/Users/devan/OneDrive/Desktop/Projects/AI Moonshots/moonshot-llm-genome/research/CLAIM_EVIDENCE_MAP.md:103>). g183 asks the right causal question: can we construct the useful interface prior from corpus/tokenizer statistics alone? Its prereg is already drafted with hard criteria [genome_183 prereg](<C:/Users/devan/OneDrive/Desktop/Projects/AI Moonshots/moonshot-llm-genome/research/prereg/genome_183_corpus_derived_init_2026-04-29.md:66>).

Do not resurrect pre-pivot surgery/grafting unless there is a new mechanism; WIKI says that whole branch mostly died: surgery KILL, grafting 12 KILL/NULL [WIKI.md](<C:/Users/devan/OneDrive/Desktop/Projects/AI Moonshots/moonshot-llm-genome/WIKI.md:443>).

**2. Does g180b Change g182?**

Cell design: **mostly no.** g182 already exists because g180/g180b are weak: true Qwen/GPT-2 architectures, LOAO, 9 baselines, block bootstrap, Model B reference-free geometry [genome_182 prereg](<C:/Users/devan/OneDrive/Desktop/Projects/AI Moonshots/moonshot-llm-genome/research/prereg/genome_182_triage_arena_2026-04-29.md:65>).

Interpretation gate: **yes.** Full Model A with Qwen-reference features is now suspect. If Model A passes but Model B fails, call it leakage. If Model B passes and Model A fails, I would treat that as the real positive signal despite the current prereg calling it weak.

Success probability drops. As written, full PASS maybe **10-15%**. Clean Model-B residual signal maybe **20-30%**. Interesting-but-not-8.0 weak pass maybe **35-40%**. GPT-2 being the only g180b win keeps g182 alive, but it also warns that the signal may be tokenizer-neighborhood, not universal geometry.

**3. Single Highest-Leverage Post-g182 Experiment**

Run **g184: Strict Residualized SSM Triage**.

Reuse g182, add a native-tokenizer SSM/hybrid family, train on two families and test on the third, with the primary model limited to pure/reference-free geometry. Labels residualized against arm/protocol and combined telemetry. Probe/eval disjoint. Add OOD labels. PASS requires >25% MSE reduction over the best non-geometry baseline with seed-block CI > 0.

That one experiment attacks the two biggest objections at once: A12 arm/protocol confound and g182’s Transformer-only limitation.

**4. Trajectory**

Current trajectory: **5/10. Not publishable yet.**

The old “Neural Genome transfer” story is dead. CLAUDE already marks that as retired, with the live framing now training-health prediction [CLAUDE.md](<C:/Users/devan/OneDrive/Desktop/Projects/AI Moonshots/moonshot-llm-genome/CLAUDE.md:11>). g180b makes that pivot cleaner but harsher.

Not a dead end yet. The project is converging on a real question: **does early interface/geometry predict run health beyond loss, protocol, and telemetry?** If g182 Model B/residual passes, this becomes publishable. If g182 loses to `arm_mean` or `combined_telemetry`, stop the forecast line and pivot to g183/interface-prior or energy-efficiency/derivation work.

